Skip to content
JournalsWorldThe Global Research Discovery Platform
Login Sign Up

Academic Journal

Q1

HemaSphere

John Wiley and Sons Inc

United StatesHematology (Q1)ISSN-matched source record
Submission information ↗
Q1Ranking
—Impact Factor (year unverified)
42H-index (SCImago 2025)
2.001SJR (2025)
2017-2026Coverage

About HemaSphere

HemaSphere is a scholarly journal published by John Wiley and Sons Inc. SCImago 2025 lists it in Q1, with an SJR of 2.001 and H-index of 42.

Coverage: 2017-2026. Research categories: Hematology (Q1).

Open-access policies and author information

Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.

Accepted manuscript languagesEnglish
Licence optionsCC BY, CC BY-NC, CC BY-NC-ND
Peer-review processDouble anonymous peer review
APCDOAJ-reported APC: 2880 USD; 2130 GBP; 2500 EUR
Waiver policy reportedYes
Other fees reportedNo
Author retains unrestricted copyrightNo
Digital preservationCLOCKSS, PMC, Portico
Reported submission-to-publication time7 weeks on average; not a guarantee
Openly licensed content since2017 (not the journal founding year)

Publisher policy links recorded by DOAJ

Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.

Source-backed journal facts

ISSN(s)2572-9241
ISSN-L2572-9241
Source typeJournal
Publisher / hosting organisationWolters Kluwer
Publisher country codeUS
Fully open access (OpenAlex)Yes
DOAJ flag (OpenAlex)Listed in OpenAlex metadata; confirm current status in DOAJ
Works recorded in OpenAlex9,451
Citations recorded in OpenAlex19,929
OpenAlex H-index53
Years represented in OpenAlex1959–2026 (not the founding or closing dates)

Topics in published research

Acute Myeloid Leukemia Research; Chronic Lymphocytic Leukemia Research; Lymphoma Diagnosis and Treatment; Multiple Myeloma Research and Treatments; Myeloproliferative Neoplasms: Diagnosis and Treatment; Chronic Myeloid Leukemia Treatments.

OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.

Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.

Found incorrect or outdated information?Help us keep this profile accurate.
Suggest an Edit